Health - General (GHG) — Title 17. Laboratories
Statutes in effect as of October 1, 2026.
Subtitle 1. Public Health and Clinical Laboratories
Md. Code Ann., Health-Gen. § 17-101 (2026)
Title 17. Laboratories
Subtitle 1. Public Health and Clinical Laboratories
§ 17–101LinkCopy Citation
The Secretary shall determine the number and location of public health laboratories and maintain those laboratories as needed to provide testing, consulting, and regulatory support of infectious disease, epidemiology, environmental, and regulatory public health programs.
Md. Code Ann., Health-Gen. § 17-102 (2026)
Title 17. Laboratories
Subtitle 1. Public Health and Clinical Laboratories
§ 17–102LinkCopy Citation
A public health and clinical laboratory shall provide services in connection with:
(1)
Any inquiry that the Department or any health officer or physician makes about a communicable disease;
(2)
Any inquiry that the Department makes about sewage;
(3)
Any inquiry that the Department makes about a trade waste;
(4)
Any inquiry the Department makes about a nuisance;
(5)
Any examination or analysis of a water supply;
(6)
Any examination or analysis of milk; and
(7)
Any inquiry about any other matter that the Secretary requires.
Md. Code Ann., Health-Gen. § 17-103 (2026)
Title 17. Laboratories
Subtitle 1. Public Health and Clinical Laboratories
§ 17–103LinkCopy Citation
(a)
Except as otherwise provided, the Secretary may set a fee for any service of a public health and clinical laboratory in accordance with § 2–104 of this article.
(b)
Except as provided in subsection (c) of this section, the Secretary may not impose any fee for any service of a public health and clinical laboratory in connection with:
(1)
An examination or analysis of a water supply;
(2)
An examination or analysis of milk; or
(3)
An inquiry that any health officer or physician makes about a communicable disease.
(c)
Subsection (b)(2) of this section does not apply to the production of farmstead cheese.
Md. Code Ann., Health-Gen. § 17-103.1 (2026)
Title 17. Laboratories
Subtitle 1. Public Health and Clinical Laboratories
§ 17–103.1LinkCopy Citation
(a)
In this section, “Fund” means the Laboratory Testing Fund.
(b)
There is a Laboratory Testing Fund in the Department for the provision of laboratory services associated with the production of farmstead cheese.
(c)
The Department shall administer the Fund.
(d)
(1)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)
Any unspent portion of the Fund and any investment earnings of the Fund may not be transferred or revert to the General Fund of the State, but shall remain in the Fund.
(e)
The Fund consists of any laboratory testing fees collected by the Department for laboratory services associated with the production of farmstead cheese.
(f)
The Fund shall only be used to support the operations of the Laboratories Administration.
Md. Code Ann., Health-Gen. § 17-104 (2026)
Title 17. Laboratories
Subtitle 1. Public Health and Clinical Laboratories
§ 17–104LinkCopy Citation
(a)
(1)
In this section the following words have the meanings indicated.
(2)
“Mutual aid agreement” means a written agreement between a public health laboratory in the State and a public health laboratory operated by another state to establish and carry out a plan to assist each other in providing temporary testing services to alleviate an emergency at one of the laboratories.
(3)
“Public health laboratory” means a laboratory operated by a state government to provide:
(i)
Consulting and regulatory support of infectious disease, epidemiology, environmental, and regulatory public health programs; and
(ii)
Tests or examinations in connection with:
(1)
The diagnosis and control of human diseases;
(2)
The assessment of human health, nutritional, or medical conditions; or
(3)
The environment.
(b)
This section shall be liberally construed to promote its purpose of providing aid during an emergency at a public health laboratory.
(c)
(1)
A public health laboratory in the State may enter into or renew a mutual aid agreement with a public health laboratory operated by another state.
(2)
A public health laboratory operated by another state that enters into a mutual aid agreement shall provide written documentation of the statutory authority required for that state to meet the responsibilities set forth in the agreement.
(3)
(i)
Except as provided in subparagraph (ii) of this paragraph, a mutual aid agreement shall provide that the party requesting assistance under the agreement shall indemnify and hold harmless the public health laboratory that provides assistance and its authorized personnel from any claim by a third party for property damage, personal injury, or wrongful death that arises out of activities, including travel, that are authorized by the agreement.
(ii)
The party that requests assistance need not indemnify the party that provides assistance if:
(1)
The party that provides assistance does not cooperate in defending against a claim made by a third party;
(2)
The claim by a third party arises out of a malicious or grossly negligent act of the party that provides assistance; or
(3)
The claim by a third party arises out of an act that is outside of the scope of the duties under the agreement of the party that provides assistance.
(4)
A mutual aid agreement shall provide that each party to the agreement shall waive any claim against any other parties to the agreement if the claim arises out of the activities of a party that are within the scope of the agreement and that are performed without malice or gross negligence.
(d)
(1)
Subject to paragraph (2) of this subsection, an employee of a public health laboratory who has been trained and certified by the director of the employee’s public health laboratory may travel to and provide services at the location of the emergency under a mutual aid agreement at the request of the Secretary, the Secretary’s designee, or an individual from another state with equivalent authority under the agreement.
(2)
An employee may not travel to or provide services at the location of the emergency under a mutual aid agreement until the Secretary, the Secretary’s designee, or equivalent authority in another state approves the employee to travel to and provide services at the location of the emergency.
(e)
For purposes of workers’ compensation law or any other employment benefit that would apply to an individual who is performing a service for a public health laboratory under a mutual aid agreement:
(1)
The individual is considered to have performed that service in the course of employment as a State employee and in the line of duty; and
(2)
The workers’ compensation law or employment benefit of the state that employs the individual shall be provided by that state when an individual is performing a service in another state.
(f)
Necessary expenditures made under a mutual aid agreement or otherwise made under this section may be charged against any State or local appropriations that are usually available to a public health laboratory.
Subtitle 2. Medical Laboratories
Md. Code Ann., Health-Gen. § 17-201 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–201LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“License” means a permit, letter of exception, certificate, or other document issued by the Secretary granting approval or authority to:
(1)
Offer or perform medical laboratory tests or examinations in this State;
(2)
Offer or perform medical laboratory tests or examinations on specimens acquired from health care providers in this State at a medical laboratory located outside this State; or
(3)
Represent or service in this State a medical laboratory regardless of the laboratory’s location.
(c)
(1)
“Medical laboratory” means any facility, entity, or site that offers or performs tests or examinations in connection with the diagnosis and control of human diseases or the assessment of human health, nutritional, or medical conditions or in connection with job-related drug and alcohol testing.
(2)
“Medical laboratory” includes any laboratory owned or operated by the State or owned or operated by a county or municipal corporation in the State.
Md. Code Ann., Health-Gen. § 17-202 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–202LinkCopy Citation
(a)
(1)
The Secretary shall adopt regulations that set standards and requirements for medical laboratories.
(2)
The regulations shall contain the standards and requirements that the Secretary considers necessary to assure the citizens of this State that medical laboratories provide safe and reliable services.
(b)
To assure compliance with the standards and requirements adopted in regulations pursuant to this subtitle, the Secretary shall:
(1)
Conduct an inspection of each medical laboratory for which a license to operate is sought; and
(2)
Conduct an inspection periodically of each medical laboratory for which a license has been issued.
(c)
(1)
In addition to the regulations adopted under subsection (a) of this section, the Secretary shall adopt regulations establishing specific standards for medical laboratories engaged in cytology, including regulations that:
(i)
Limit the number of slides an individual may examine;
(ii)
Require that the examination of cytology slides be performed in a medical laboratory that has a license issued by the Secretary;
(iii)
Prohibit payment to cytotechnologists for the examination of cytology specimens or slides on a piecework basis;
(iv)
Require cytology laboratories to review no less than 10 percent of all negative gynecological slides;
(v)
Require that the cytology review be performed by an individual who qualifies as a supervisory cytotechnologist or a pathologist;
(vi)
Require the individual who directs the laboratory to establish and administer an ongoing quality assurance program using standards acceptable to the Secretary;
(vii)
Require cytology laboratories to reject unsatisfactorily prepared specimens, make appropriate comments regarding the quality of the specimen, and maintain records on unsatisfactorily prepared specimens for 5 years subject to review by the Department;
(viii)
Require cytology laboratories to maintain and store for 5 years from the date of examination any slide that was examined;
(ix)
Require all cytology reports to be retained for at least 10 years;
(x)
Prohibit any person from sending cytology specimens to a laboratory, including out–of–state laboratories, not licensed by the Department;
(xi)
Require all individuals who examine gynecological slides acquired from persons in this State to demonstrate satisfactory performance in an approved cytology proficiency testing program; and
(xii)
Establish any additional standards the Secretary considers necessary to assure that medical laboratories engaged in cytology provide safe and reliable services.
(2)
The requirements of paragraph (1) of this subsection are in addition to any other relevant provision of this subtitle or relevant regulation adopted in accordance with any other provision of this subtitle governing medical laboratories.
(d)
(1)
To assure compliance with standards adopted under subsection (c) of this section, the Secretary shall adopt regulations to establish and conduct a cytology proficiency testing program for all cytology personnel that examine gynecological cytology specimens.
(2)
All cytology proficiency tests under the State cytology proficiency testing program shall be conducted by an employee of the Maryland Department of Health who shall:
(i)
Hand carry all testing materials to the testing site; and
(ii)
Directly supervise the on–site proficiency testing.
(3)
The Secretary shall adopt regulations for the cytology proficiency testing program that:
(i)
Define satisfactory cytology proficiency testing performance; and
(ii)
Set standards and requirements that a cytology proficiency testing program must meet before it can be designated an approved program.
(4)
The Secretary may accept the testing results of an approved cytology proficiency testing program as meeting the cytology proficiency testing requirement of this subtitle.
Md. Code Ann., Health-Gen. § 17-202.1 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–202.1LinkCopy Citation
(a)
On written request of an individual to a medical laboratory for a copy of the results of a laboratory examination of that individual, the medical laboratory shall send a copy of those results that are sought to that individual.
(b)
(1)
If the results of a laboratory examination are contained in or will be filed in a medical record, as defined in § 4-301 of this article, the request for a copy of the results shall be made to the facility pursuant to the provisions of § 4-302 of this article.
(2)
In all other cases, the medical laboratory may require the individual requesting a copy of the results to pay the prevailing cost of copying and transmitting the copy.
(c)
The medical laboratory shall notify the individual’s physician before sending the results to the individual.
Md. Code Ann., Health-Gen. § 17-203 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–203LinkCopy Citation
(a)
The Secretary may adopt regulations that set qualifications for the following personnel of medical laboratories:
(1)
Directors;
(2)
Supervisory technologists;
(3)
Technologists;
(4)
Cytotechnologists; and
(5)
Supervisory cytotechnologists.
(b)
The director of a medical laboratory is not required to be a physician licensed under the Health Occupations Article.
Md. Code Ann., Health-Gen. § 17-205 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–205LinkCopy Citation
(a)
Except as provided in §§ 10–14A–03 and 10–14B–03 of the State Government Article, a person shall hold a license issued by the Secretary before the person may:
(1)
Offer or perform medical laboratory tests or examinations in this State;
(2)
Offer or perform medical laboratory tests or examinations on specimens acquired from health care providers in this State at a medical laboratory located outside this State; or
(3)
Represent or service in this State a medical laboratory regardless of the laboratory’s location.
(b)
The Secretary shall issue a letter of exception to a laboratory that:
(1)
Performs only limited medical laboratory tests or examinations; and
(2)
Meets the exception requirements in regulations adopted by the Secretary pursuant to this subtitle.
(c)
For the purposes of this section, “limited medical laboratory tests or examinations” means medical laboratory procedures as defined in regulations adopted by the Secretary pursuant to this subtitle.
(d)
If preliminary screening procedures are performed by an operator who is trained under § 17–214(k) of this subtitle, an employer:
(1)
Is not required to obtain a permit or to obtain a letter of exception from the Secretary under this section to perform testing; but
(2)
Is required before performing preliminary screening procedures, as defined under § 17–214(a) of this subtitle, to register with the Secretary in accordance with requirements adopted in regulations by the Maryland Department of Health.
Md. Code Ann., Health-Gen. § 17-206 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–206LinkCopy Citation
To qualify for a license, an applicant shall provide evidence to satisfy the Secretary that the medical laboratory and its personnel meet the standards and requirements of the subtitle and in regulations adopted by the Secretary pursuant to this subtitle.
Md. Code Ann., Health-Gen. § 17-207 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–207LinkCopy Citation
(a)
An applicant for a license shall submit an application to the Secretary on the form that the Secretary requires.
(b)
An application for a license to operate a medical laboratory shall include:
(1)
The name of the owner;
(2)
The classes of services, complexity of testing, or the tests or examinations that the medical laboratory would provide; and
(3)
Any other information that the Secretary requires.
Md. Code Ann., Health-Gen. § 17-208 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–208LinkCopy Citation
(a)
The Secretary shall issue a license to any applicant who meets the standards and requirements of this subtitle and in regulations adopted pursuant to this subtitle.
(b)
A medical laboratory license shall include the name of the:
(1)
Medical laboratory;
(2)
Laboratory director; and
(3)
Owner of the laboratory.
(c)
A medical laboratory license shall designate the:
(1)
Complexity of testing that the laboratory may offer or perform;
(2)
Classes of services that may be offered;
(3)
Tests or examinations that may be offered or performed by the laboratory; or
(4)
Any combination of items (1), (2), and (3) of this subsection.
(d)
A medical laboratory may not operate in any manner beyond what is designated by its license.
(e)
A medical laboratory license issued by the Secretary under this subtitle is not transferable.
Md. Code Ann., Health-Gen. § 17-210 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–210LinkCopy Citation
(a)
The Secretary may deny a license to any applicant or suspend, revoke, or limit a license or the authority to offer or perform any class of service, complexity of testing, or tests that the license sets forth, if the medical laboratory or its director or other personnel fail to meet the standards and requirements under this subtitle and in regulations adopted pursuant to this subtitle.
(b)
(1)
If the Secretary finds that a laboratory issued a license under this subtitle no longer meets the standards and requirements under this subtitle and in regulations adopted pursuant to this subtitle, the Secretary may impose a directed plan of correction or limit the testing authorized by the license instead of suspending or revoking a license.
(2)
(i)
If the Secretary finds that a medical laboratory provided erroneous or questionable test results that pose a threat to the health and safety of patients, the Secretary may order the laboratory to:
(1)
Notify the physicians or other individuals who ordered the tests of the erroneous or questionable test results; and
(2)
Take any additional measures necessary to reduce or eliminate the threat to the health and safety of patients, including the notification of patients and the offering of retests.
(ii)
A medical laboratory that fails to comply with an order issued by the Secretary under subparagraph (i) of this paragraph is subject to a civil penalty of up to $1,000 for each day of noncompliance after the deadline for compliance stated in the Secretary’s order, not to exceed a maximum penalty of $50,000, instead of or in addition to any other sanction imposed under this section.
(c)
Except as otherwise provided in the Administrative Procedure Act, before the Secretary denies, suspends or revokes a license, or imposes a civil penalty under this section, the Secretary shall give the applicant or licensee notice and an opportunity for a hearing.
Md. Code Ann., Health-Gen. § 17-211 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–211LinkCopy Citation
(a)
A laboratory issued a license under this subtitle shall enroll in and continue to demonstrate satisfactory performance as defined by the Secretary by regulations in a proficiency testing program or programs approved by the Secretary.
(b)
The Secretary shall adopt regulations that:
(1)
Define satisfactory proficiency testing performance; and
(2)
Set the standards and requirements that a proficiency testing program must meet before it can be designated as an approved program.
Md. Code Ann., Health-Gen. § 17-212 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–212LinkCopy Citation
Unless a person holds a license issued by the Secretary the person may not:
(1)
Offer or perform medical laboratory tests or examinations in this State;
(2)
Represent or service in this State a medical laboratory regardless of the laboratory’s location; or
(3)
Offer or perform medical laboratory tests or examinations on specimens acquired from health care providers in this State at a medical laboratory located outside this State.
Md. Code Ann., Health-Gen. § 17-213 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–213LinkCopy Citation
Unless a medical laboratory has a valid license, no other person on the laboratory’s behalf may:
(1)
Offer or perform medical laboratory tests or examinations in this State;
(2)
Offer or perform medical laboratory tests or examinations on specimens acquired from health care providers in this State at the medical laboratory located outside this State; or
(3)
Represent or service in this State the medical laboratory regardless of the laboratory’s location.
Md. Code Ann., Health-Gen. § 17-214 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–214LinkCopy Citation
(a)
(1)
In this section the following words have the meanings indicated.
(2)
“Alcohol or controlled dangerous substance testing” means a procedure used to determine whether or not a specimen contains a controlled dangerous substance or alcohol.
(3)
“Certification” means the approval granted by the Department for a laboratory to engage in job–related alcohol or controlled dangerous substance testing.
(4)
“Controlled dangerous substance” has the meaning stated in § 5–101 of the Criminal Law Article.
(5)
“Job applicant” means an individual who:
(i)
Has applied for a position with an employer; and
(ii)
Is not currently employed by the employer.
(6)
“Job–related” means any alcohol or controlled dangerous substance testing used by an employer for a legitimate business purpose.
(7)
“Laboratory” means a facility or other entity that conducts job–related alcohol or controlled dangerous substance testing.
(8)
“Medical review officer” means a licensed physician with knowledge of drug abuse disorders and drug and alcohol testing.
(9)
“Preliminary screening procedure” means a controlled dangerous substance test that uses a single–use test device that:
(i)
Is easily portable and can be administered at a work site or other appropriate collection site;
(ii)
Meets the requirements of the federal Food and Drug Administration for commercial distribution; and
(iii)
Meets generally accepted cutoff levels such as those in the federal Substance Abuse and Mental Health Services Administration Guidelines for drug–free workplace testing programs.
(10)
“Single–use test device” means the reagent–containing unit of a test system that:
(i)
Is in the form of a sealed container or cartridge that has a validity check, a nonresealable closure, or an evidentiary tape that ensures detection of any tampering;
(ii)
Is self–contained and individually packaged;
(iii)
Is discarded after each test; and
(iv)
Does not allow any test component or constituent of a test system to interact between tests.
(11)
“Specimen” means:
(i)
Blood derived from the human body;
(ii)
Urine derived from the human body;
(iii)
Hair derived from the human body as provided in subsection (b)(3) of this section; or
(iv)
Saliva derived from the human body.
(b)
(1)
Except as provided in paragraph (2) of this subsection, an employer who requires any person to be tested for job–related reasons for the use or abuse of any controlled dangerous substance or alcohol shall:
(i)
Have the specimen tested by a laboratory that:
(1)
Holds a permit under this subtitle; or
(2)
Is located outside of the State and is certified or otherwise approved under subsection (f) of this section; and
(ii)
At the time of testing, at the person’s request, inform the person of the name and address of the laboratory that will test the specimen.
(2)
(i)
(1)
Except as provided in subsubparagraph 2 of this subparagraph, an employer may use a preliminary screening procedure to test a job applicant for the use or abuse of any controlled dangerous substance.
(2)
Subsubparagraph 1 of this subparagraph does not apply to an employer that has entered into a collective bargaining agreement that prohibits the employer from using a preliminary screening procedure to test a job applicant for the use or abuse of any controlled dangerous substances.
(ii)
If the result of a preliminary screening procedure is positive, the employer shall submit the specimen for testing by a laboratory as required under paragraph (1) of this subsection.
(iii)
Following voluntary disclosure and documentation by an applicant of the taking of a legally prescribed medication, an employer may hire the applicant pending confirmation of a positive test result by the medical laboratory and review by the employer’s medical review officer.
(iv)
An employer may not use a preliminary screening procedure to test an individual who is not applying for a job with that employer.
(v)
An employer may designate a medical laboratory licensed to perform job–related testing for controlled dangerous substances to also perform preliminary screening procedures on job applicants for the employer.
(3)
(i)
An employer who requires any person to be tested for job–related reasons for the use or abuse of any controlled dangerous substance may use hair derived from the human body as a specimen in accordance with this paragraph.
(ii)
An employer may use hair derived from the human body only for pre–employment purposes.
(iii)
If an employer uses hair derived from the human body as a specimen, the employer may not:
(1)
Use a specimen that is longer than one and one–half inches measured from the human body; or
(2)
Use the specimen for any purpose other than testing for controlled dangerous substances.
(c)
(1)
An employer who requires any employee, contractor, or other person to be tested for job–related reasons for the use or abuse of any controlled dangerous substance or alcohol and who receives notice from the laboratory under subsection (b) of this section that an employee, contractor, or other person has tested positive for the use or abuse of any controlled dangerous substance or alcohol shall, after confirmation of the test result, provide the employee, contractor, or other person with:
(i)
A copy of the laboratory test indicating the test results;
(ii)
A copy of the employer’s written policy on the use or abuse of controlled dangerous substances or alcohol by employees, contractors, or other persons;
(iii)
If applicable, written notice of the employer’s intent to take disciplinary action, terminate employment, or change the conditions of continued employment; and
(iv)
A statement or copy of the provisions set forth in subsection (e) of this section permitting an employee to request independent testing of the same sample for verification of the test result.
(2)
The information required to be provided to the employee, contractor, or other person under paragraph (1) of this subsection shall be delivered to the employee, contractor, or other person:
(i)
Either in person or by certified mail; and
(ii)
Within 30 days from the date the test was performed.
(d)
An employer that uses a preliminary screening procedure to test specimens for the use or abuse of a controlled dangerous substance under this section shall:
(1)
In using a single–use test device, collect, handle, store, and ship each specimen in a manner that:
(i)
Maintains the specimen donor’s identity and confidentiality and the physical integrity of the specimen; and
(ii)
Precludes contamination of the specimen; and
(2)
Maintain a written record of the chain of custody of each specimen from the time that the specimen is collected until the time that the specimen is no longer needed for retesting.
(e)
(1)
A person who is required to submit to job–related testing, under subsection (b) or (c) of this section, may request independent testing of the same specimen for verification of the test results by a laboratory that:
(i)
Holds a permit under this subtitle; or
(ii)
If located outside of the State, is certified or otherwise approved under subsection (f) of this section.
(2)
The person shall pay the cost of an independent test conducted under this subsection.
(f)
(1)
The Maryland Department of Health:
(i)
Shall adopt regulations governing the certification of laboratories that conduct job–related alcohol or controlled dangerous substance testing; and
(ii)
May adopt regulations governing the oversight of preliminary screening procedures administered by employers.
(2)
In addition to any other laboratory standards, the regulations shall:
(i)
Require that the laboratory comply with the guidelines for laboratory accreditation, if any, as set forth by the College of American Pathologists, the Centers for Medicare and Medicaid Services, or any other government agency or program designated to certify or approve a laboratory that is acceptable to the Secretary;
(ii)
Require that a laboratory performing confirmation tests for controlled dangerous substances or alcohol be inspected and accredited in forensic drug analysis by the College of American Pathologists, the Centers for Medicare and Medicaid Services, or any other government agency or program designated to inspect and accredit a laboratory that is acceptable to the Secretary;
(iii)
Require that, if the laboratory performs job–related drug testing, the laboratory be a participant in a program of proficiency testing of drug screening conducted by an organization acceptable to the Secretary;
(iv)
Require that the laboratory comply with standards regarding cutoff levels for positive testing that are established by the United States Department of Health and Human Services or established by the Secretary as mandatory guidelines for workplace drug testing programs; and
(v)
Include procedures for inspection.
(g)
This section does not apply to:
(1)
Alcohol or controlled dangerous substance testing of a person under arrest or held by a law enforcement or correctional agency;
(2)
Alcohol testing procedures conducted by a law enforcement or correctional agency on breath testing equipment certified by the toxicologist in the Department of State Police Forensic Sciences Division; or
(3)
Controlled dangerous substance testing by a laboratory facility of a law enforcement or correctional agency that maintains laboratory testing standards comparable to the standards in this section.
(h)
This section applies to job–related alcohol and controlled dangerous substance testing of any person, including preemployment applicants, employees, and contractors.
(i)
(1)
Except as provided in paragraphs (2) and (3) of this subsection, in the course of obtaining information for, or as a result of, conducting job–related alcohol or controlled dangerous substance testing for an employer under this section, a laboratory, a physician, including a physician retained by the employer, or any other person may not reveal to the employer information regarding:
(i)
The use of a nonprescription drug, excluding alcohol, that is not prohibited under the laws of the State; or
(ii)
The use of a medically prescribed drug, unless the person being tested is unable to establish that the drug was medically prescribed under the laws of the State.
(2)
The prohibitions against disclosure of information under paragraph (1) of this subsection do not apply to the extent that they prevent a person from complying with the applicable provisions of the federal Commercial Motor Vehicle Safety Act of 1986 and the federal Motor Carrier Safety Regulations.
(3)
The prohibitions against disclosure of information under paragraph (1) of this subsection do not apply if, prior to the administration of a preliminary screening for controlled dangerous substances, the test operator notifies the applicant that if the preliminary test is positive, the applicant may voluntarily disclose and provide documentation to the operator that the applicant is taking a legally prescribed medication.
(j)
(1)
An employer using preliminary screening procedures to test job applicants under this section shall have a medical review officer review a positive test result after laboratory confirmation of the positive test result.
(2)
The employer may contract for the services of an outside medical review officer if the employer does not have a medical review officer on staff.
(k)
(1)
An employer using preliminary screening procedures shall establish a program to train individuals to collect specimens and perform controlled dangerous substance tests in the workplace.
(2)
The employer may designate an employee or any other individual to be trained, including any individual employed by a medical laboratory designated under subsection (b)(2)(v) of this section who will perform preliminary screening procedures for the employer.
(3)
A trainee shall receive appropriate and practical instruction, which includes:
(i)
A reading of the test manufacturer’s package insert sheet;
(ii)
Observing the test manufacturer’s training video or receiving training from the test manufacturer;
(iii)
Completing the test manufacturer’s self–administered test; and
(iv)
The actual performance of tests and the actual interpretation of the results.
(4)
(i)
The employer shall:
(1)
Keep a record of the training received by each trainee; and
(2)
Establish a procedure for training each trainee as having received the minimum training required to properly perform the test.
(ii)
After the trainee has demonstrated competency in performing the test, the employer shall maintain documentation that indicates that the trainee has been trained under this section.
(l)
The provisions of a collective bargaining agreement that concern drug testing override and preempt the provisions of this section that authorize an employer to use a preliminary screening procedure to test a job applicant.
Md. Code Ann., Health-Gen. § 17-215 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–215LinkCopy Citation
(a)
Except as provided in subsection (b) of this section, a person may not directly or indirectly advertise for or solicit business in this State for any medical laboratory, regardless of location, from anyone except a physician, hospital, medical laboratory, clinic, clinical installation, or other medical care facility.
(b)
(1)
(i)
This subsection applies only to:
(1)
A diagnostic laboratory test or procedure for the purpose of screening, diagnosing, managing, or treating a physical or mental condition or disease; and
(2)
Ancestry testing using Y–chromosome mitochondrial DNA or autosomal DNA testing limited to the detection and reporting of genetic evidence of parental lineage and genetic ethnicity.
(ii)
This subsection does not apply to germline genetic or genomic testing done in connection with the analysis, diagnosis, or prediction of human diseases.
(2)
Subject to paragraph (3) of this subsection, a person may directly or indirectly advertise for or solicit business in the State for a diagnostic laboratory test or procedure ordered by a physician and performed by a medical laboratory certified under 42 U.S.C. § 263a.
(3)
A person that directly or indirectly advertises for or solicits business in the State for a diagnostic laboratory test or procedure under this subsection:
(i)
Is a covered entity or business associate of a covered entity for purposes of the federal Health Insurance Portability and Accountability Act of 1996 and the federal Health Information Technology for Economic and Clinical Health Act;
(ii)
May not make a claim about the reliability and validity of the test or procedure that is inconsistent with the test or procedure’s performance as measured under 42 U.S.C. § 263a; and
(iii)
Shall disclose that the diagnostic laboratory test or procedure may or may not be covered by health insurance.
(4)
The Secretary may take legal action to restrict the marketing of a diagnostic laboratory test or procedure if the Secretary determines that:
(i)
There is a public health threat; or
(ii)
The diagnostic laboratory test or procedure is not in compliance with the requirements of this section.
Md. Code Ann., Health-Gen. § 17-216 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–216LinkCopy Citation
A person who violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $100 for the first offense and not exceeding $500 for each subsequent conviction for a violation of the same provision. Each day a violation is continued after the first conviction is a subsequent offense.
Md. Code Ann., Health-Gen. § 17-217 (2026)
Title 17. Laboratories
Subtitle 2. Medical Laboratories
§ 17–217LinkCopy Citation
(a)
The Secretary shall establish a Laboratory Advisory Committee to advise the Secretary on matters relating to the implementation of the provisions of this subtitle.
(b)
The Advisory Committee shall consist of:
(1)
At least the following representatives appointed biennially from a list of eligibles:
(i)
1 member of the American Academy of Family Practitioners;
(ii)
1 member of the American Academy of Pediatricians;
(iii)
1 member of the American College of Physicians;
(iv)
1 member of the American Society for Clinical Pathology; and
(v)
1 member of the American College of Pathology; and
(2)
1 representative of the Advanced Medical Technology Association.
(c)
The Secretary may appoint any other individuals or representatives at the Secretary’s discretion.
(d)
The chairman of the Advisory Committee shall be designated by the Secretary every 2 years.
Subtitle 2A. Forensic Laboratories
Md. Code Ann., Health-Gen. § 17-2A-01 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-01LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
(1)
“Forensic analysis” means a medical, chemical, toxicologic, firearms, or other expert examination or test performed on physical evidence, including DNA evidence, for the purpose of determining the connection of the evidence to a criminal act.
(2)
“Forensic analysis” includes an examination or test required by a law enforcement agency, prosecutor, criminal suspect or defendant, or court.
(3)
“Forensic analysis” does not include:
(i)
A test of a specimen of breath or blood to determine alcohol concentration or controlled dangerous substance content;
(ii)
Forensic information technology;
(iii)
A presumptive test performed at a crime scene;
(iv)
A presumptive test performed for the purpose of determining compliance with a term or condition of community supervision or parole and conducted by or under contract with a county department of corrections or the State Department of Public Safety and Correctional Services; or
(v)
An expert examination or test conducted principally for the purpose of scientific research, medical practice, civil or administrative litigation, or any other purpose unrelated to determining the connection of physical evidence to a criminal act.
(c)
“Forensic information technology” means digital or electronic evidence that is stored or transmitted electronically.
(d)
(1)
“Forensic laboratory” means a facility, entity, or site that offers or performs forensic analysis.
(2)
“Forensic laboratory” includes a laboratory owned or operated by the State, a county or municipal corporation in the State, or another governmental entity.
(3)
“Forensic laboratory” does not include:
(i)
A forensic laboratory operated by the federal government; or
(ii)
A laboratory licensed or certified by the Department of Agriculture.
(e)
“License” means a permit, letter of exception, certificate, or other document issued by the Secretary granting approval or authority to offer or perform forensic laboratory tests, examinations, or analyses in the State.
(f)
“Limited forensic analysis” means a forensic laboratory test or analysis defined in regulations adopted by the Secretary.
(g)
“Physical evidence” means any object, thing, or substance relating to a criminal act.
Md. Code Ann., Health-Gen. § 17-2A-02 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-02LinkCopy Citation
(a)
(1)
The Secretary shall adopt regulations that set standards and requirements for forensic laboratories.
(2)
The regulations shall contain the standards and requirements that the Secretary considers necessary to assure the citizens of the State that forensic laboratories provide safe, reliable, and accurate services.
(3)
The regulations shall:
(i)
Require the director of a forensic laboratory to establish and administer an ongoing quality assurance program using standards acceptable to the Secretary;
(ii)
Require the director of a forensic laboratory to retain all case files for at least 10 years;
(iii)
Establish qualifications for the personnel of forensic laboratories;
(iv)
Establish procedures for verifying the background and education of the personnel of forensic laboratories; and
(v)
Establish any additional standards that the Secretary considers necessary to assure that forensic laboratories provide accurate and reliable services.
(b)
(1)
A forensic laboratory that examines or analyzes physical evidence shall demonstrate satisfactory performance in an approved proficiency testing program specifically related to the particular forensic analysis being performed.
(2)
The Secretary shall adopt regulations for the forensic proficiency testing program that:
(i)
Define satisfactory proficiency testing performance; and
(ii)
Set standards and requirements that a forensic proficiency testing program shall meet.
(3)
The Department shall review a forensic laboratory’s proficiency testing program.
(c)
To assure compliance with the standards and requirements under this subtitle, the Secretary shall conduct:
(1)
An inspection of each forensic laboratory for which a license to operate is sought; and
(2)
An inspection of each forensic laboratory for which a license has been issued.
(d)
To assure compliance with the standards and requirements under this subtitle, the Secretary may conduct:
(1)
A complaint investigation; and
(2)
A validation survey of an accredited forensic laboratory.
Md. Code Ann., Health-Gen. § 17-2A-03 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-03LinkCopy Citation
(a)
Forensic laboratory deficiency statements and plans of correction are public documents.
(b)
A forensic laboratory shall make discrepancy logs, contamination records, and test results available to the public within 30 days of a written request.
(c)
Except as provided in subsection (a) of this section, the proceedings, records, and files of an organization or State agency responsible for assuring compliance with this subtitle shall be confidential and not discoverable or admissible in evidence in a civil or criminal action.
Md. Code Ann., Health-Gen. § 17-2A-04 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-04LinkCopy Citation
(a)
After December 31, 2011, a forensic laboratory shall hold a license issued by the Secretary before the forensic laboratory may offer or perform forensic analysis in the State.
(b)
The Secretary shall issue a letter of exception to a laboratory that:
(1)
Performs only limited forensic analysis; and
(2)
Meets the exception requirements in regulations adopted by the Secretary.
(c)
The Secretary may grant an out–of–state forensic laboratory a waiver from the licensure requirements of this subtitle with conditions.
Md. Code Ann., Health-Gen. § 17-2A-05 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-05LinkCopy Citation
To qualify for a license, an applicant shall provide evidence to satisfy the Secretary that the forensic laboratory and its personnel meet the standards and requirements of this subtitle.
Md. Code Ann., Health-Gen. § 17-2A-06 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-06LinkCopy Citation
(a)
An applicant for a license shall submit an application to the Secretary on the form that the Secretary requires.
(b)
An application for a license to operate a forensic laboratory shall include:
(1)
The name of the operator or owner;
(2)
The tests or examinations that the forensic laboratory would provide; and
(3)
Any other information that the Secretary requires.
Md. Code Ann., Health-Gen. § 17-2A-07 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-07LinkCopy Citation
(a)
The Secretary shall issue a license to an applicant that meets the standards and requirements of this subtitle.
(b)
A forensic laboratory license shall include the name of the:
(1)
Forensic laboratory;
(2)
Laboratory director; and
(3)
Operator or owner of the laboratory.
(c)
A forensic laboratory license shall designate the tests, examinations, or analyses that may be offered or performed by the laboratory.
(d)
A forensic laboratory may not operate in a manner not designated by the license issued under this subtitle.
(e)
A forensic laboratory license issued by the Secretary under this subtitle is not transferable.
Md. Code Ann., Health-Gen. § 17-2A-09 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-09LinkCopy Citation
(a)
The Secretary may deny a license to an applicant or suspend, revoke, or limit a license or the authority of a licensee to offer or perform tests that a license sets forth, if the forensic laboratory or its director or other personnel fail to meet the standards and requirements of this subtitle.
(b)
(1)
If the Secretary finds that a forensic laboratory licensed under this subtitle no longer meets the standards and requirements of this subtitle, the Secretary may:
(i)
Revoke the license of the forensic laboratory; or
(ii)
Suspend the license of the forensic laboratory.
(2)
If a deficiency exists, the Secretary may:
(i)
Impose a directed plan of correction;
(ii)
Regularly inspect the forensic laboratory to assure compliance with the directed plan of correction; or
(iii)
Limit the testing authorized by the license.
(c)
If the Secretary finds that a forensic laboratory provided erroneous or questionable test results, the Secretary may order the laboratory to provide written notification to:
(1)
The person or agency that ordered the tests;
(2)
The Office of the Public Defender or counsel of record; and
(3)
The State’s Attorney.
(d)
A State’s Attorney who receives notification from a laboratory under subsection (c) of this section shall notify the victim of the criminal act or the victim’s representative of the erroneous or questionable test results.
(e)
A forensic laboratory that fails to comply with an order issued by the Secretary under subsection (c) of this section is subject to a civil penalty of up to $1,000 for each day of noncompliance after the deadline for compliance stated in the Secretary’s order, not to exceed a maximum penalty of $50,000.
(f)
Except as otherwise provided in the Administrative Procedure Act, before the Secretary denies, suspends, or revokes a license, or imposes a civil penalty under this section, the Secretary shall give the applicant or licensee notice and an opportunity for a hearing.
Md. Code Ann., Health-Gen. § 17-2A-10 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-10LinkCopy Citation
(a)
In this section, “discriminate or retaliate” includes:
(1)
Failing to promote an individual or to provide another employment–related benefit for which the individual would otherwise be eligible;
(2)
Making an adverse evaluation or decision in relation to accreditation, certification, credentialing, or licensing of the individual; or
(3)
Taking a personnel action that is adverse to the individual concerned.
(b)
An employee who works in a forensic laboratory may disclose information to the Secretary that the employee believes evidences a violation of standards and requirements for forensic laboratories in the State.
(c)
A forensic laboratory may not discriminate or retaliate against an employee because the employee:
(1)
Discloses information under subsection (b) of this section; or
(2)
Has agreed to cooperate with an investigation of the forensic laboratory.
(d)
(1)
The Secretary shall develop, through regulation, a document that informs the employees of a forensic laboratory of the procedures to report instances of noncompliance or other violations of the standards and requirements for forensic laboratories in the State.
(2)
The Secretary shall distribute the document developed under paragraph (1) of this subsection to forensic laboratories in the State.
(e)
A forensic laboratory shall post the document developed under subsection (d) of this section in a conspicuous place.
(f)
An employee of a forensic laboratory who has been discriminated or retaliated against in violation of subsection (c) of this section may initiate an action and, on prevailing, shall be entitled to:
(1)
Reinstatement;
(2)
Reimbursement for lost wages;
(3)
Work benefits lost as a result of the unlawful acts of the employing laboratory; and
(4)
Reasonable attorney’s fees and costs associated with pursuing the action.
(g)
No action may be brought under this subsection more than 2 years after the discrimination or retaliation that is the basis for the action.
Md. Code Ann., Health-Gen. § 17-2A-11 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-11LinkCopy Citation
(a)
A person that violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to:
(1)
A fine not exceeding $100 for the first offense; and
(2)
A fine not exceeding $500 for each subsequent conviction for a violation of the same provision.
(b)
Each day on which a violation occurs is a separate violation under this section.
Md. Code Ann., Health-Gen. § 17-2A-12 (2026)
Title 17. Laboratories
Subtitle 2A. Forensic Laboratories
§ 17–2A-12LinkCopy Citation
(a)
The Governor shall establish a Forensic Laboratory Advisory Committee to advise the Secretary on matters relating to the implementation of the provisions of this subtitle.
(b)
The Advisory Committee shall consist of the following 10 members:
(1)
The Director of the Laboratories Administration in the Department, or the Director’s designee;
(2)
The Director of the Office of Health Care Quality in the Department, or the Director’s designee; and
(3)
The following members, appointed by the Governor:
(i)
One from the American Society for Clinical Laboratory Science;
(ii)
One from the University of Maryland School of Medicine, Department of Medical Research and Technology;
(iii)
One from the American Association for Laboratory Accreditation;
(iv)
One from the American Academy of Forensic Sciences;
(v)
One from the ANSI–ASQ National Accreditation Board; and
(vi)
Three directors of forensic laboratories in the State, including:
(1)
One from a forensic laboratory operated by the State;
(2)
One from a forensic laboratory operated by a county; and
(3)
One from a forensic laboratory operated by a municipal corporation.
(c)
(1)
The term of an appointed member is 3 years.
(2)
The terms of appointed members are staggered as required by the terms provided for appointed members of the Advisory Committee on October 1, 2007.
(d)
The Governor shall designate the chair of the Advisory Committee.
(e)
A majority of the members serving on the Advisory Committee represents a quorum to conduct business.
(f)
A member of the Advisory Committee may not receive compensation but is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(g)
The Department shall provide staff for the Advisory Committee.
Subtitle 3. Tissue Banks
Md. Code Ann., Health-Gen. § 17-301 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–301LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Permit” means a permit issued by the Secretary:
(1)
To operate a tissue bank in this State; or
(2)
To represent or service in this State a tissue bank that is outside this State.
(c)
(1)
“Tissue bank” means an establishment that obtains, stores, processes, distributes, or sells human blood or other human tissue for use in the human body.
(2)
“Tissue bank” includes a blood bank.
Md. Code Ann., Health-Gen. § 17-302 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–302LinkCopy Citation
(a)
(1)
The Secretary shall adopt rules and regulations that set standards for tissue banks.
(2)
The rules and regulations shall contain the standards that the Secretary considers necessary to assure the citizens of this State that tissue banks provide safe and reliable services.
(b)
To assure compliance with the standards adopted under this subtitle, the Secretary shall:
(1)
Have an inspection made of each tissue bank for which a permit to operate is sought; and
(2)
Have an inspection made periodically or make an agreement with an organization to do, at no cost to this State, a periodic inspection of each tissue bank for which a permit has been issued.
Md. Code Ann., Health-Gen. § 17-303 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–303LinkCopy Citation
(a)
The Secretary shall adopt rules and regulations that set qualifications for directors of tissue banks.
(b)
The rules and regulations shall require that a tissue bank in this State employ or retain under contract:
(1)
A technical director, qualified by training and experience for the scope of activities being pursued, who will oversee and be responsible for all technical aspects of the tissue bank’s operations; and
(2)
A medical director who will be a physician licensed to practice medicine in this State and who will be responsible for all medical aspects of the tissue bank’s operations, unless the technical director qualifies as a medical director under this section.
Md. Code Ann., Health-Gen. § 17-305 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–305LinkCopy Citation
Except as provided in §§ 10–14A–03 and 10–14B–03 of the State Government Article, a person shall hold a permit issued by the Secretary before the person may:
(1)
Operate a tissue bank in this State; or
(2)
Represent or service in this State any tissue bank that is outside this State.
Md. Code Ann., Health-Gen. § 17-306 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–306LinkCopy Citation
To qualify for a permit, an applicant shall satisfy the Secretary that the tissue bank to be operated, represented, or serviced and its director meet the requirements that the Secretary adopts under this subtitle.
Md. Code Ann., Health-Gen. § 17-307 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–307LinkCopy Citation
(a)
An applicant for a permit shall submit an application to the Secretary on the form that the Secretary requires.
(b)
(1)
An application for a permit to operate a tissue bank shall include:
(i)
The name of the owner;
(ii)
The classes of services that the tissue bank would provide; and
(iii)
Any other information that the Secretary requires.
(2)
An application for a permit to represent or service a tissue bank shall include satisfactory evidence that the tissue bank to be represented or serviced and its director meet the requirements that the Secretary adopts under this subtitle.
Md. Code Ann., Health-Gen. § 17-308 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–308LinkCopy Citation
(a)
The Secretary shall issue a permit to any applicant who meets the requirements of this subtitle.
(b)
The Secretary shall include on each permit that the Secretary issues:
(1)
The name of the tissue bank;
(2)
The name of its director;
(3)
The name of its owner; and
(4)
The classes of services that the tissue bank may offer.
Md. Code Ann., Health-Gen. § 17-309 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–309LinkCopy Citation
While it is effective, a permit authorizes the permit holder:
(1)
To operate or to represent or service the tissue bank named in the permit; and
(2)
To offer and perform the classes of services set forth in the permit.
Md. Code Ann., Health-Gen. § 17-311 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–311LinkCopy Citation
(a)
The Secretary may deny a permit to any applicant or suspend or revoke a permit or the authority to offer or perform any class of service that the permit sets forth, if the tissue bank or its director fails to meet the requirements that the Secretary adopts under this subtitle.
(b)
Except as otherwise provided in the Administrative Procedure Act, before the Secretary takes any action under this section, the Secretary shall give the applicant or permit holder notice and an opportunity for a hearing.
Md. Code Ann., Health-Gen. § 17-312 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–312LinkCopy Citation
(a)
A person may not operate a tissue bank in this State unless the person holds a permit issued by the Secretary.
(b)
A permit holder may not offer or perform any class of service of a tissue bank that is not authorized by the permit.
Md. Code Ann., Health-Gen. § 17-313 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–313LinkCopy Citation
(a)
A person may not represent or service any tissue bank, regardless of location, unless the tissue bank and its director meet the standards and qualifications that the Secretary adopts under this subtitle.
(b)
A person may not represent or service in this State any tissue bank that is not in this State unless the person holds a permit to represent or service the tissue bank.
Md. Code Ann., Health-Gen. § 17-314 (2026)
Title 17. Laboratories
Subtitle 3. Tissue Banks
§ 17–314LinkCopy Citation
A person who violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $100 for the first offense and not exceeding $500 for each subsequent conviction for a violation of the same provision. Each day a violation is continued after the first conviction is a subsequent offense.
Subtitle 5. Cholesterol Testing
Md. Code Ann., Health-Gen. § 17-501 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–501LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Cholesterol testing” includes collecting a test specimen, testing to detect the amount of cholesterol in an individual’s blood, and the reporting of test results.
(c)
“Permit” means a permit issued by the Secretary to a person who:
(1)
Offers to provide, with or without charge, a test to detect the amount of cholesterol in an individual’s blood; and
(2)
Conducts the test outside a permanently located medical laboratory issued a permit or excepted from a permit under Subtitle 2 of this title.
Md. Code Ann., Health-Gen. § 17-502 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–502LinkCopy Citation
(a)
Except as provided under subsection (b) of this section and § 17-503 of this subtitle, a person shall obtain a permit from the Department before:
(1)
Offering to provide a test to detect the amount of cholesterol in an individual’s blood; and
(2)
Conducting the cholesterol test outside a permanently located medical laboratory issued a permit or excepted from a permit under Subtitle 2 of this title.
(b)
A cholesterol testing permit is not required under this subtitle for a medical laboratory that:
(1)
Is licensed under Subtitle 2 of this title; and
(2)
As set forth in the license, provides tests or services in the discipline of chemistry or health awareness.
Md. Code Ann., Health-Gen. § 17-503 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–503LinkCopy Citation
(a)
Any local or county health department may submit to the Secretary its cholesterol testing plan for review.
(b)
(1)
The Secretary shall review all submissions under this section as soon as reasonably possible after the submission in order to determine whether it meets the standards necessary for adequate off-site cholesterol testing in accordance with this subtitle.
(2)
If a plan submitted under this section meets the standards of this subtitle, the Secretary may waive the permit requirements of the subtitle and permit the submitting local or county health department to conduct cholesterol testing under this subtitle for a period of 12 months, provided that:
(i)
The submission adequately describes the cholesterol testing plan for the effective 12 months;
(ii)
The local or county health department provides all information that the Secretary may reasonably require to determine compliance with this section;
(iii)
The local or county health department agrees to make records available and submit reports to the Secretary as the Secretary may require;
(iv)
Changes and amendments to the plan are submitted 60 days prior to proposed implementation; and
(v)
All changes and amendments to the plan are approved by the Secretary.
(3)
If a plan submitted under this section does not meet the standards of this subtitle, or if the information supplied in the submission is considered by the Secretary to be insufficient for a determination, the submitting local or county health department shall apply for a permit in accordance with this subtitle.
(c)
The Secretary may cancel a waiver granted under this section at any time if the Secretary finds that the local or county health department does not continue to meet the standards of this subtitle.
Md. Code Ann., Health-Gen. § 17-504 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–504LinkCopy Citation
(a)
The Secretary shall adopt regulations to implement the provisions of this subtitle, including regulations that assure the citizens of this State that cholesterol testing conducted outside a permanently located medical laboratory meets appropriate national standards of quality assurance.
(b)
The regulations shall include:
(1)
Personnel training standards, including requirements for reasonable training, experience, and competency in:
(i)
Simple procedures used in drawing blood for cholesterol testing; and
(ii)
The operation of blood chemical analyzers used for cholesterol screening;
(2)
Quality assurance standards;
(3)
Standards for counseling and referral procedures;
(4)
Standards for releasing and reporting test results; and
(5)
A prohibition on the payment of any sum to any person for bringing or referring a patient.
(c)
(1)
The Secretary may not require that cholesterol testing personnel that conduct cholesterol tests under this subtitle be certified in a medical laboratory specialty.
(2)
All cholesterol testing conducted under this subtitle shall be overseen by a supervisor knowledgeable in all aspects of cholesterol testing services.
Md. Code Ann., Health-Gen. § 17-505 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–505LinkCopy Citation
To qualify for a permit, an applicant shall meet the requirements of this subtitle and any regulation that the Secretary adopts under this subtitle.
Md. Code Ann., Health-Gen. § 17-506 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–506LinkCopy Citation
An applicant for a permit shall submit an application to the Secretary on the form that the Secretary requires.
Md. Code Ann., Health-Gen. § 17-507 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–507LinkCopy Citation
(a)
The Secretary shall issue a permit to any applicant who meets the requirements of this subtitle.
(b)
The Secretary shall include on each permit:
(1)
The name of the permittee;
(2)
The address of the permittee; and
(3)
The expiration date of the permit.
Md. Code Ann., Health-Gen. § 17-509 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–509LinkCopy Citation
(a)
The Secretary may deny a permit to an applicant or suspend or revoke an existing permit for failure to comply with the provisions of this subtitle and any regulation adopted under this subtitle.
(b)
Except as otherwise provided in the Administrative Procedure Act, before the Secretary takes any action under this section, the Secretary shall give the applicant or permit holder notice and an opportunity for a hearing.
Md. Code Ann., Health-Gen. § 17-510 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–510LinkCopy Citation
(a)
Except as otherwise provided in this title, a person may not offer cholesterol testing in this State unless the person holds a permit from the Secretary.
(b)
The permit is not transferable.
Md. Code Ann., Health-Gen. § 17-511 (2026)
Title 17. Laboratories
Subtitle 5. Cholesterol Testing
§ 17–511LinkCopy Citation
A person who violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $100 for the first offense and not exceeding $500 for each subsequent conviction for a violation of the same provision. Each day a violation is continued after the first conviction is a subsequent offense.
Subtitle 6. Biological Agents Registry Program
Md. Code Ann., Health-Gen. § 17-601 (2026)
Title 17. Laboratories
Subtitle 6. Biological Agents Registry Program
§ 17–601LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Biological agent” means any biological agent as defined in Title 42, Part 73 of the Code of Federal Regulations, or Title 9, Part 121 of the Code of Federal Regulations.
(c)
“Maryland Institute for Emergency Medical Services Systems” means the unit described in § 13-503 of the Education Article.
(d)
“Person” includes State and federal units of government.
(e)
“Program” means the Biological Agents Registry Program.
Md. Code Ann., Health-Gen. § 17-602 (2026)
Title 17. Laboratories
Subtitle 6. Biological Agents Registry Program
§ 17–602LinkCopy Citation
(a)
There is a Biological Agents Registry Program in the Department.
(b)
The Biological Agents Registry shall:
(1)
Identify the biological agents possessed and maintained by any person in this State; and
(2)
Contain other information as required by regulations adopted by the Department.
(c)
The Department shall adopt regulations for the implementation of the Program that:
(1)
Determine and list the biological agents required to be reported under this subtitle;
(2)
Designate the persons required to make reports and the specific information required to be reported;
(3)
Designate time limits for reporting, the form of reports, and the persons to whom reports are to be submitted;
(4)
Require local jurisdictions to be informed of the location and nature of each biological agent in the Registry that is located within the local jurisdiction;
(5)
Provide for the release of information in the Biological Agents Registry to:
(i)
State and federal law enforcement agencies and the Centers for Disease Control and Prevention pursuant to a communicable disease investigation commenced or conducted by the Department or other State or federal law enforcement agency having investigatory authority, or in connection with any investigation involving release, theft, or loss of biological agents;
(ii)
The Maryland Department of Emergency Management and the Maryland Department of the Environment for the purposes of planning for the protection of the public in relation to the release of a biological agent and the prevention of a release of a biological agent; and
(iii)
The Maryland Institute for Emergency Medical Services Systems for the purposes of providing certain specified information to:
(1)
A police officer, as defined in § 3–201(f) of the Public Safety Article, responding to an emergency; and
(2)
A fire, rescue, or emergency medical services entity, as defined in § 7–101 of the Public Safety Article, performing emergency services, responding to a fire or other emergency, or dispatched on a call for emergency services;
(6)
Establish a system of safeguards that requires persons possessing, maintaining, and transferring biological agents subject to this subtitle to comply with the same federal standards that apply to persons registered to transfer the same agents under federal law; and
(7)
Establish a process for persons that possess and maintain biological agents to alert appropriate authorities of unauthorized possession or attempted possession of biological agents.
Md. Code Ann., Health-Gen. § 17-603 (2026)
Title 17. Laboratories
Subtitle 6. Biological Agents Registry Program
§ 17–603LinkCopy Citation
(a)
Except as provided in subsection (b) of this section, any person that possesses and maintains any biological agent shall report to the Department the information required by the Department for inclusion in the Biological Agents Registry.
(b)
Subsection (a) of this section does not apply to a biological agent or a certified laboratory or facility that is exempt from the requirements for the interstate shipment of etiologic agents under Title 42, Part 72.6(h) or Part 72, Appendix A of the Code of Federal Regulations.
Md. Code Ann., Health-Gen. § 17-604 (2026)
Title 17. Laboratories
Subtitle 6. Biological Agents Registry Program
§ 17–604LinkCopy Citation
(a)
Except as otherwise provided in this subtitle, information prepared for or maintained in the Biological Agents Registry shall be confidential and is not subject to Title 4 of the General Provisions Article.
(b)
Release of information from the Registry as authorized by regulations adopted under § 17-602(c) of this subtitle shall not render the information released a public record.
(c)
A person or entity to whom specified information has been released from the Registry as authorized by regulations adopted under § 17-602(c) of this subtitle may not release the information unless the release is approved by the Biological Agents Registry Program.
Md. Code Ann., Health-Gen. § 17-605 (2026)
Title 17. Laboratories
Subtitle 6. Biological Agents Registry Program
§ 17–605LinkCopy Citation
(a)
A person who violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $100 for the first offense and not exceeding $500 for each subsequent conviction for a violation of the same provision.
(b)
Each day a violation is continued after the first conviction is a subsequent offense.
Subtitle 7. Biosafety Level 3 (bsl–3) Laboratories in Frederick County
Md. Code Ann., Health-Gen. § 17-701 (2026)
Title 17. Laboratories
Subtitle 7. Biosafety Level 3 (bsl–3) Laboratories in Frederick County
§ 17–701LinkCopy Citation
(a)
In this section, “BSL–3 laboratory” means a laboratory designated as a biosafety level 3 (BSL–3) laboratory by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, Biosafety in Microbiological and Biomedical Laboratories, as applicable, based on:
(1)
Usage of biological agents that may cause serious or potentially lethal disease after inhalation, ingestion, or absorption; and
(2)
Required biocontainment precautions.
(b)
This section applies to each BSL–3 laboratory in Frederick County that:
(1)
Does not work with federally regulated biological select agents and toxins or their products; and
(2)
(i)
Is a commercial or for–profit laboratory;
(ii)
Is owned by or is part of a teaching hospital or an institution of postsecondary education; or
(iii)
Is a privately funded biomedical research laboratory.
(c)
The Department shall develop and make available a standardized form for a BSL–3 laboratory subject to this section to use to provide the information required under subsection (d) of this section.
(d)
On or before October 30 each year, each BSL–3 laboratory subject to this section shall report to the Department:
(1)
The address of the laboratory;
(2)
The name, telephone number, and e–mail address of a contact person for the laboratory; and
(3)
Any other information required by the Department to determine the location of the laboratory.
(e)
On or before December 31 each year, the Department shall report to:
(1)
The Maryland Department of Emergency Management and the health officer and emergency management officials of Frederick County the number and location of BSL–3 laboratories subject to this section; and
(2)
The Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly the total number of BSL–3 laboratories subject to this section.
(f)
(1)
Except as provided in paragraph (2) of this subsection and subsection (e) of this section, any information the Department collects from BSL–3 laboratories subject to this section is confidential and not subject to inspection under the Public Information Act.
(2)
Any information the Department collects from BSL–3 laboratories subject to this section shall be made available if requested by the BSL–3 laboratory’s insurance carrier or in a legal proceeding.
(g)
(1)
Activity of a BSL–3 laboratory subject to this section that fails to report the information required under subsection (d) of this section shall be considered ultrahazardous and abnormally dangerous.
(2)
A BSL–3 laboratory subject to this section that fails to report the information required under subsection (d) of this section is strictly liable for damages for any injury, death, or loss to person or property that is caused by the BSL–3 laboratory.